Muscle Relaxation Injection for wrinkles [Botox®]

Wrinkle Relaxing Injections, (known as Botox® ) removes laughter lines, crows feet and facial creases, administered effectively and safely by using a very fine needle.

The signs of ageing are erased by relaxing the dynamic facial muscles that are responsible for facial wrinkles, smoothing out the skin giving a softer and more youthful appearance. The main areas treated are the frown, eye and forehead. After a few injections you can carry on your normal day Botox® (Botulinum toxin type A) injections are now the UK's no 1 treatment for facial lines and wrinkles simply because it really does remove the telltale signs of ageing.

Muscle Relaxation Injection for Wrinkles

The main action is to selectively paralyze the muscles which case wrinkles by excessive contraction. The toxin can be injected into specific muscles to temporarily relax them resulting in an inability to wrinkle the skin overlying the treated muscle. The toxin is only helpful for dynamic wrinkles, also known as "wrinkles in motion."

It is not as effective on static wrinkles, "wrinkles at rest," but prolonged use of botulinum toxin may help prevent wrinkles in motion from becoming wrinkles at rest.

The toxin can also be combined with dermal fillers and resurfacing techniques to optimize patient satisfaction. The upper part of the face contains distinct muscle groups that can be selectively paralyzed by a knowledgeable injector.

In the lower part of the face, the muscle groups are less distinct making it much more difficult to accurately inject these muscles.

The Procdure for Botox Injection

BOTOX® Cosmetic - Injection Locations

It can be injected to the following sites:

• The glabelar muscles of the forehead, which gives an angry look.
• The orbicularis oculi, which creates wrinkles around the eyes.
• The frontalis, which creates the wrinkles of the forehead

Procedure Length

The injection itself takes a few minutes.

The docotr uses a special syringe and injects a small amount of botox to the muscles involved.

Men usually require larger amount due to larger muscles.

The effect takes place after a day or two and reaches its maximal effect after 10 days. The pain involving the injection usually well tolerated by most of the patients and there is no need in local anesthetics.

Duration effect

The duration of the effect is usually 3 month for full effect and 8 month for partial effect. Longer action cases muscle fibers to degenerate therefore it is recommended to repeat the treatment after 3-4 month. After several treatments there are longer periods of time with full effect and usually much less botox required to achieve it. Many patients enjoy even the partial effect for long periods of time.

There is no permanent effect.

Risks

The treatment proved to be relatively safe.

Precautions include: know allergy to botox or albumin, muscle weakness, use of aminoglicozide antibiotics, pregnancy or breastfeeding.

Common side effects include: bleeding around the injection sites, headache, flu like symptoms and local pain. Another unwanted effect is paralysis of adjacent muscles which may cause eyelid drop (usually partial), double vision and difficulty swallowing.

Because only part of those muscles was paralyzed there is usually a full compensation of the remaining muscle after 2-4 weeks

Please see below for non-promotional reference information:

For general reference information visit: www.botoxcosmetic.com

Safety

The American Society for Aesthetic Plastic Surgery (ASAPS) estimates that almost 3.3 million treatments using wrinkle reducing treatments were performed in 2005.

Efficacy

In clinical trials, nearly 90% of men and women surveyed rated the improvement in the appearance of frown lines between their brows as moderate to better 1 month after treatment. Results vary. Results can last for up to 4 months, and may vary.

Regulatory Status

BOTOX® was approved by the Food and Drug Administration (FDA) in 2002 for the temporary treatment of moderate to severe frown lines between the brows in people ages 18 to 65, and almost 3.3 million procedures were performed in 2005 alone. Botox® was approved by the MHRA (UK regulatory authority) in 2006.

For more complete information please see:
www.botoxcosmetic.com

Botox® is a trademark of Allergan

References:

1. Ahn MS, Catten M, Maas CS. Temporal brow lift using botulinum toxin A. Plast Reconstr Surg. Mar 2000;105(3):1129-35; discussion 1136-9. [Medline].
2. Beer K, Yohn M, Closter J. A double-blinded, placebo-controlled study of Botox for the treatment of subjects with chin rhytids. J Drugs Dermatol. Jul-Aug 2005;4(4):417-22. [Medline].
3. Benedetto AV. The cosmetic uses of Botulinum toxin type A. Int J Dermatol. Sep 1999(9):641-55. [Medline].
4. Brin MF, Lew MF, Adler CH, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A- resistant cervical dystonia. Neurology. Oct 22 1999;53(7):1431-8. [Medline].
5. Carruthers A, Carruthers J. Cosmetic uses of botulinum A exotoxin. Adv Dermatol. 1997;12:325-47; discussion 348. [Medline].
6. Carruthers A, Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg. Nov 1998;24(11):1189-94. [Medline].
7. Clemente CD. Anatomy: A Regional Atlas of the Human Body. Baltimore-Munich:. Urban & Schwarzenberg;1981.
8. Dayan SH, Kempiners JJ. Treatment of the lower third of the nose and dynamic nasal tip ptosis with Botox. Plast Reconstr Surg. May 2005;115(6):1784-5. [Medline].
9. Edelstein C, Shorr N, Jacobs J, et al. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Dermatol Surg. Nov 1998;24(11):1208-12. [Medline].
10. Erbguth FJ, Naumann M. Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the "sausage poison". Neurology. Nov 10 1999;53(8):1850-3. [Medline].
11. Garcia A, Fulton JE Jr. Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study. Dermatol Surg. Jan 1996;22(1):39-43. [Medline].
12. Gartlan MG, Hoffman HT. Crystalline preparation of botulinum toxin type A (Botox): degradation in potency with storage. Otolaryngol Head Neck Surg. Feb 1993;108(2):135-40. [Medline].
13. Hankins CL, Strimling R, Rogers GS. Botulinum A toxin for glabellar wrinkles. Dose and response. Dermatol Surg. Nov 1998;24(11):1181-3. [Medline].
14. Hoefflin SM. Anatomy of the platysma and lip depressor muscles. A simplified mnemonic approach. Dermatol Surg. Nov 1998;24(11):1225-31. [Medline].
15. Kane MA. Nonsurgical treatment of platysmal bands with injection of botulinum toxin A [published erratum appears in Plast Reconstr Surg 1999 Mar;103(3):following table of contents]. Plast Reconstr Surg. Feb 1999;103(2):656-63; discussion 664-5. [Medline].
16. Knize DM. An anatomically based study of the mechanism of eyebrow ptosis. Plast Reconstr Surg. Jun 1996;97(7):1321-33. [Medline].
17. Niamtu J 3rd. Aesthetic uses of botulinum toxin A. J Oral Maxillofac Surg. Oct 1999;57(10):1228-33. [Medline].
18. Pribitkin EA, Greco TM, Goode RL, Keane WM. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection. Arch Otolaryngol Head Neck Surg. Mar 1997;123(3):321-6. [Medline].
19. Schantz EJ, Johnson EA. Preparation and characterization of botulinum toxin type A for human treatment. In: Jankovik J, Hallet M, eds. Therapy with Botulinum Toxin. Vol 109. New York, NY:. Marcel Dekker;1994:10-24.
20. Schiavo G, Benfenati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. Oct 29 1992;359(6398):832-5. [Medline].
21. Schmidt RD, Schmidt TW. Infant botulism: a case series and review of the literature. J Emerg Med. Nov-Dec 1992;10(6):713-8. [Medline].
22. Scott AB. In: Jankovik J, Hallet M, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker;1994:vii-ix.